Sangamo Therapeutics
SGMO
SGMO
126 hedge funds and large institutions have $127M invested in Sangamo Therapeutics in 2016 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 40 increasing their positions, 32 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% more funds holding
Funds holding: 124 → 126 (+2)
36% less capital invested
Capital invested by funds: $196M → $127M (-$69.7M)
Holders
126
Holding in Top 10
–
Calls
$3.12M
Puts
$1.03M
Top Buyers
| 1 | +$2.56M | |
| 2 | +$1.53M | |
| 3 | +$1.22M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.06M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$837K |
Top Sellers
| 1 | -$4.64M | |
| 2 | -$4.16M | |
| 3 | -$4.03M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$3.78M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$2.3M |